IRIS
DE LUCA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.349
NA - Nord America 8.120
AS - Asia 4.807
SA - Sud America 1.325
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 3
Totale 22.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.968
IE - Irlanda 2.795
DE - Germania 1.499
SG - Singapore 1.445
HK - Hong Kong 1.124
UA - Ucraina 1.108
CN - Cina 1.056
SE - Svezia 1.029
BR - Brasile 1.016
RU - Federazione Russa 728
VN - Vietnam 611
FI - Finlandia 545
IN - India 215
IT - Italia 201
GB - Regno Unito 130
AR - Argentina 122
FR - Francia 105
CA - Canada 84
ID - Indonesia 78
KR - Corea 63
MX - Messico 53
IR - Iran 49
EC - Ecuador 48
PL - Polonia 41
ZA - Sudafrica 41
PY - Paraguay 40
CO - Colombia 39
BD - Bangladesh 34
NL - Olanda 31
AT - Austria 27
ES - Italia 26
VE - Venezuela 23
IQ - Iraq 22
JP - Giappone 20
BE - Belgio 18
CL - Cile 17
CZ - Repubblica Ceca 16
MA - Marocco 16
TR - Turchia 16
PK - Pakistan 14
EU - Europa 12
LT - Lituania 12
RO - Romania 11
TN - Tunisia 11
KZ - Kazakistan 10
SA - Arabia Saudita 10
UY - Uruguay 9
BJ - Benin 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
JO - Giordania 5
KE - Kenya 5
IL - Israele 4
NP - Nepal 4
RS - Serbia 4
UZ - Uzbekistan 4
AL - Albania 3
BW - Botswana 3
BY - Bielorussia 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CG - Congo 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 22.719
Salva come PNG Salva come JPEG
Città #
Dublin 2.795
Jacksonville 1.914
Hong Kong 1.123
Dearborn 1.051
Wilmington 701
Singapore 473
Beijing 444
Ashburn 389
Lawrence 382
Princeton 382
Moscow 289
San Mateo 261
Chandler 254
Ho Chi Minh City 229
Los Angeles 205
Ann Arbor 168
Bremen 165
Andover 163
Buffalo 151
Hanoi 115
São Paulo 97
Hefei 73
Redondo Beach 70
Düsseldorf 67
Houston 67
Nanjing 64
Seoul 63
New York 54
Norwalk 54
Woodbridge 51
Kunming 50
Munich 49
Rio de Janeiro 41
Dallas 40
Piemonte 40
Leawood 36
Fairfield 35
Jinan 35
Helsinki 33
Monmouth Junction 33
Tianjin 31
Denver 30
Warsaw 30
Haiphong 29
Nuremberg 29
Toronto 28
Guangzhou 26
Johannesburg 24
Santa Clara 24
Seattle 24
Montreal 23
Ardabil 22
Biên Hòa 21
Torino 20
Frankfurt am Main 19
Nanchang 19
Stockholm 19
Tokyo 19
Brussels 18
Chennai 18
Poplar 18
Da Nang 17
London 17
Mexico City 17
Quito 17
Brno 16
Bắc Ninh 16
Campinas 16
Dong Ket 16
Hebei 16
Atlanta 15
Brasília 15
Guarulhos 15
Guayaquil 15
Chicago 14
Jakarta 14
Manchester 14
Ribeirão Preto 14
Shenyang 14
Belo Horizonte 13
Bexley 13
Boardman 13
Phoenix 13
Xian 13
Amsterdam 12
Boston 12
Curitiba 12
Salvador 12
San Francisco 12
Zanjan 12
Bogotá 11
Brooklyn 11
Buenos Aires 11
Fuzhou 11
Orem 11
Ottawa 11
Sorocaba 11
Thái Bình 11
Augusta 10
Bắc Giang 10
Totale 13.720
Salva come PNG Salva come JPEG
Nome #
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 115
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 109
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 106
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 104
ACC/AHA and ESC guidelines 103
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 102
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 102
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 102
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 101
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 100
PCI techniques 100
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 100
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 100
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 99
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 98
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 98
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 98
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 96
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 95
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 95
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 94
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 94
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 94
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 93
Adjuncitve pharmacotherapy: Anticoagulation 92
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 92
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 92
Apical-sparing Tako-tsubo: A case report 91
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 91
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 91
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 91
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 91
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 90
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 90
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 90
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 89
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 89
Pharmacological facilitation in primary angioplasty: myth or reality? 88
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 87
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 87
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 87
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 87
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 87
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 86
A meta-analytic overview of thrombectomy during primary angioplasty 85
Redefining the success of mechanical reperfusion: ST-segment resolution 85
An unusual case of ECG ST-segment elevation 85
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 85
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 85
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 85
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 85
Mechanical prevention of distal embolization: Rationale and trial results 84
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 84
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 84
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 83
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 83
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 83
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 83
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 82
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 82
Balloon angioplasty or BMS? 81
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 81
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 81
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 81
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 80
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 80
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 80
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 79
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 79
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 79
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 79
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 78
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 78
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 77
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 77
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 77
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 77
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 76
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 76
Immature platelet fraction and the extent of coronary artery disease: A single centre study 76
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 76
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 76
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 76
LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY PREDICTING FUNCTIONAL RECOVERY AFTER CORONARY REVASCULARIZATION 75
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 75
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 75
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 75
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 75
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 74
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 74
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 74
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 74
Prediction of long-term effetcs of revascularization on regional and global left ventricular function by dobutamine echocardiography and rest Tl-201 imaging alone and in combination in patients with chronic coronary artery disease 73
Left ventricular angiography and other angiocardiographic techniques 73
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 73
Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM dual-therapy stent: What we plan to learn from REDUCE 73
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 73
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 73
Rheolytic thrombectomy during percutaneous coronary intervention improves long-term outcome in high-risk patients with acute myocardial infarction 73
Adjunctive antithrombotic therapy during Primary PCI 72
Totale 8.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.246 0 0 0 0 0 50 344 6 388 35 395 28
2021/20222.083 72 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/20264.595 364 374 1.088 1.920 737 112 0 0 0 0 0 0
Totale 23.481